The following is the summary of “National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support” published in the January 2023 issue of Thoracic and cardiovascular surgery by Melehy, et al.
Read the article by Physician’s Weekly.
“Use of temporary mechanical circulatory support (MCS) as a bridge to transplantation was a good strategy for many people following implementation of the 2018 national donor heart allocation policy, yet hemodynamic criteria may need to be modified to better identify the most urgent transplant candidates.
Within 14 days of status 2 listing, people with either a percutaneous endovascular MCS device or an intra-aortic balloon pump (IABP) received a heart transplant in 64.2% of cases, and only 1.9% died or were delisted for worsening clinical condition (a figure that rose to 3.1% at 30 days on the waitlist).”
Learn more here.